Cite
HARVARD Citation
Schneider, D. et al. (2015). Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR). Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schneider, D. et al. (2015). Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR). Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].